会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • WASHER WASHING BALL INDUCTIVE DEVICE AND A DRAIN COVER FOR THE WASHING BALLS
    • 洗衣机洗衣机感应装置和洗衣机的排水盖
    • US20130127263A1
    • 2013-05-23
    • US13509024
    • 2010-11-05
    • Ho Yong Park
    • Ho Yong Park
    • H02K57/00B08B3/04
    • B08B3/04B08B9/0808B08B9/0817D06F33/02D06F35/00D06F35/008D06F39/024D06F39/083H02K99/20
    • Disclosed are a washing unit for washing contaminants within a washing machine, a permanent magnet inducing unit for effectively washing an inner wall of a water tank by using induction of an electric field or providing a motion to an artificial floating body of the water tank, and a drain cover for a washing machine for assisting a washing operation of a washing ball of the washing machine. The washing unit has a body for maintaining a certain shape such as a ball and a plurality of washing projections, and is introduced into spaces between the water container and the washing tub and between the water tank and the pulsator to frictionally remove various filths attached to the washing tank, the washing tub and the pulsator with the washing projections that floats at a predetermined depth of washing water.
    • 公开了一种用于洗涤洗衣机内的污染物的洗涤单元,用于通过使用感应电场或向水箱的人造浮体提供运动来有效地清洗水箱的内壁的永磁体诱导单元,以及 用于洗衣机的排水盖,用于帮助洗衣机的洗涤球的洗涤操作。 洗涤单元具有用于保持一定形状的主体,例如球和多个洗涤突起,并且被引入到水容器和洗涤桶之间以及在水箱和波轮之间的空间中,以摩擦地去除附接到 洗涤槽,洗涤桶和波轮,其中洗涤突起浮在洗涤水的预定深度。
    • 3. 发明申请
    • COMPOSITION CONTAINING ARAZYME FOR THE PREVENTION AND TREATMENT OF CANDER
    • 含有ARAZYME的组合物用于预防和治疗CANDER
    • US20120003204A1
    • 2012-01-05
    • US13225317
    • 2011-09-02
    • Ho-Yong PARKKwang-Hee SONDong-Ha SHINKyu-Shik JEONG
    • Ho-Yong PARKKwang-Hee SONDong-Ha SHINKyu-Shik JEONG
    • A61K38/48A61P35/00
    • A61K38/4886A23C15/065A23G1/423A23G3/366A23G4/123A23G9/363A23L2/02A23L2/66A23L13/424A23L13/48A23L23/00A23L33/19
    • The present invention relates to a pharmaceutical composition for the prevention and treatment of cancer comprising arazyme as an active ingredient. More precisely, when arazyme produced by Aranicola proteolycius was administered to the nude mice transplanted with human lung carcinoma cell line, weight gaining, inhibition of tumor cell growth and infiltration, and down-regulations of MMP-9, NF-κB and PCNA, were observed. In addition, when arazyme was treated to human breast cancer cells (MDA-MB-231), down regulations of p21, PCNA (Proliferating Cell Nuclear Antigen), VEGF (Vascular Endothelial Growth Factor), BCl2 (B-cell CLL/lymphoma 2), p-p38, PKC (Protein Kinase C) and MMP-1 (Matrix MetalloProteinase-1) which are involved in tumor cell growth, differentiation, proliferation and metastasis, were observed along with the up-regulation of catalase which inhibits tumor development. Therefore, the arazyme can be effectively used as a pharmaceutical composition for the prevention and treatment of cancer.
    • 本发明涉及一种用于预防和治疗癌症的药物组合物,其包含作为活性成分的阿拉木霉。 更准确地说,当将Aranicola proteolycius产生的arazyme给予移植有人肺癌细胞系的裸鼠,体重增加,抑制肿瘤细胞生长和浸润,以及MMP-9,NF-和Kgr B和PCNA的下调 ,观察。 另外,当将arazyme处理到人乳腺癌细胞(MDA-MB-231)时,下调p21,PCNA(增殖细胞核抗原),VEGF(血管内皮生长因子),BCl2(B细胞CLL /淋巴瘤2 ),参与肿瘤细胞生长,分化,增殖和转移的p-p38,PKC(蛋白激酶C)和MMP-1(基质金属蛋白酶-1)以及抑制肿瘤发生的过氧化氢酶的上调 。 因此,可以有效地使用胂酸盐作为预防和治疗癌症的药物组合物。
    • 5. 发明申请
    • COMPOSITION CONTAINING ARAZYME FOR THE PREVENTION AND TREATMENT OF CANCER
    • 含有ARAZYME用于预防和治疗癌症的组合物
    • US20090317374A1
    • 2009-12-24
    • US12521676
    • 2007-12-28
    • Ho-Yong ParkKwang-Hee SonDong-Ha ShinKyu-Shik Jeong
    • Ho-Yong ParkKwang-Hee SonDong-Ha ShinKyu-Shik Jeong
    • A61K38/48A61P35/00
    • A61K38/4886A23C15/065A23G1/423A23G3/366A23G4/123A23G9/363A23L2/02A23L2/66A23L13/424A23L13/48A23L23/00A23L33/19
    • The present invention relates to a pharmaceutical composition for the prevention and treatment of cancer comprising arazyme as an active ingredient. More precisely, when arazyme produced by Aranicola proteolycius was administered to the nude mice transplanted with human lung carcinoma cell line, weight gaining, inhibition of tumor cell growth and infiltration, and down-regulations of MMP-9, NF-κB and PCNA, were observed. In addition, when arazyme was treated to human breast cancer cells (MDA-MB-231), down regulations of p21, PCNA (Proliferating Cell Nuclear Antigen), VEGF (Vascular Endothelial Growth Factor), BCl2 (B-cell CLL/lymphoma 2), p-p38, PKC (Protein Kinase C) and MMP-1 (Matrix MetalloProteinase-1) which are involved in tumor cell growth, differentiation, proliferation and metastasis, were observed along with the up-regulation of catalase which inhibits tumor development. Therefore, the arazyme can be effectively used as a pharmaceutical composition for the prevention and treatment of cancer.
    • 本发明涉及一种用于预防和治疗癌症的药物组合物,其包含作为活性成分的胂酸盐。 更准确地说,当将Aranicola proteolycius产生的arazyme给予移植有人肺癌细胞系的裸鼠时,体重增加,抑制肿瘤细胞生长和浸润以及MMP-9,NF-κB和PCNA的下调均为 观察到的。 另外,当将arazyme处理到人乳腺癌细胞(MDA-MB-231)时,下调p21,PCNA(增殖细胞核抗原),VEGF(血管内皮生长因子),BCl2(B细胞CLL /淋巴瘤2 ),参与肿瘤细胞生长,分化,增殖和转移的p-p38,PKC(蛋白激酶C)和MMP-1(基质金属蛋白酶-1)以及抑制肿瘤发生的过氧化氢酶的上调 。 因此,可以有效地使用胂酸盐作为预防和治疗癌症的药物组合物。